HIV Cure? An Existing Cancer Drug Shows Promise in Killing “Silent” HIV Cells and Delaying Reinfections
scitechdaily.com
An existing blood cancer drug has shown promise in killing ‘silent’ HIV cells and delaying reinfections – a significant pre-clinical discovery that could lead to a future cure for the disease. Hidden HIV cells, known as latent infection, are responsible for the virus permanently remaining in the

Led by WEHI and The Peter Doherty Institute for Infection and Immunity (Doherty Institute) — leading medical research institutes in Melbourne, Australia — the landmark study is being translated into a new clinical trial to assess whether the blood cancer treatment can be repurposed to offer a pathway towards an HIV cure.